The National Institutes of Health has announced the start of a new trial that involves giving a third COVID-19 vaccine dose to individuals w...
The National Institutes of Health has announced the start of a new trial that involves giving a third COVID-19 vaccine dose to individuals with autoimmune diseases. The trial will also look into the possibility of ‘pausing’ autoimmune treatments that involve immunosuppressive drugs to see whether doing so will improve antibody response against the SARS-CoV-2 virus. The third COVID-19 vaccine dose … Continue reading
from SlashGear https://ift.tt/2Y39XV1
via IFTTT
from SlashGear https://ift.tt/2Y39XV1
via IFTTT
COMMENTS